Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...